BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20491710)

  • 1. The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children.
    Schulpis KH; Papastamataki M; Stamou H; Papassotiriou I; Margeli A
    Acta Paediatr; 2010 Oct; 99(10):1565-70. PubMed ID: 20491710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indices of lipid peroxidation and the ceruloplasmin-transferrin antioxidant system in donors].
    Podoprigorova VG; Kozlov AV; Azizova OA
    Lab Delo; 1989; (1):13-5. PubMed ID: 2468015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria.
    Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I
    Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
    Van Campenhout A; Van Campenhout C; Lagrou AR; Abrams P; Moorkens G; Van Gaal L; Manuel-y-Keenoy B
    Diabetes Metab Res Rev; 2006; 22(6):444-54. PubMed ID: 16506275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins.
    Chauhan A; Chauhan V; Brown WT; Cohen I
    Life Sci; 2004 Oct; 75(21):2539-49. PubMed ID: 15363659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an exchange transfusion on plasma antioxidants in the newborn.
    Lindeman JH; Lentjes EG; Houdkamp E; van Zoeren-Grobben D; Schrijver J; Berger HM
    Pediatrics; 1992 Aug; 90(2 Pt 1):200-3. PubMed ID: 1641283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum ferritin and other factors associated with iron metabolism during chronic hyperbaric exposure.
    Gilman SC; Hunter WL; Mooney LW
    Aviat Space Environ Med; 1979 Mar; 50(3):223-6. PubMed ID: 454320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron status and iron supplementation in children with classical phenylketonuria.
    Miranda da Cruz BD; Seidler H; Widhalm K
    J Am Coll Nutr; 1993 Oct; 12(5):531-6. PubMed ID: 8263269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
    Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum iron and copper status and oxidative stress in severe and mild preeclampsia.
    Serdar Z; Gür E; Develioğlu O
    Cell Biochem Funct; 2006; 24(3):209-15. PubMed ID: 15898124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indices of serum transferrin, copper and ceruloplasmin in donors].
    Guliaev EA
    Probl Gematol Pereliv Krovi; 1971 Jan; 16(1):29-31. PubMed ID: 5555057
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
    Lee DH; Zacharski LR; Jacobs DR
    Am Heart J; 2006 Jun; 151(6):1247.e1-7. PubMed ID: 16781229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antioxidant activity in diabetes mellitus.
    Jones AF; Winkles JW; Jennings PE; Florkowski CM; Lunec J; Barnett AH
    Diabetes Res; 1988 Feb; 7(2):89-92. PubMed ID: 3396268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between the copper and iron systems in hemodialysis patients and variables affecting these systems.
    Kirschbaum B
    Biol Trace Elem Res; 2000 Oct; 77(1):13-24. PubMed ID: 11097467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diet on plasma total antioxidant status in phenylketonuric patients.
    Schulpis KH; Tsakiris S; Karikas GA; Moukas M; Behrakis P
    Eur J Clin Nutr; 2003 Feb; 57(2):383-7. PubMed ID: 12571675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil.
    Barretto JR; Silva LR; Leite ME; Boa-Sorte N; Pimentel H; Purificação AC; Carvalho G; Fontes MI; Amorim T
    Nutr Res; 2008 Mar; 28(3):208-11. PubMed ID: 19083409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study].
    Molina-Arjona JA; de Bustos F; Benito-León J; Jiménez-Jiménez FJ; Rodríguez J; Trincado R; Porta-Etessan J; Vega S; Bermejo F
    Rev Neurol; 1999 Jul 1-15; 29(1):12-5. PubMed ID: 10528302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
    Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
    Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood antioxidant defense in children with malignant disease. I. Plasma antioxidant activity and level of ceruloplasmin and transferrin].
    Gajewska J; Szczypka M; Laskowska-Klita T; Perek D
    Pediatr Pol; 1995 Nov; 70(11):907-10. PubMed ID: 8677154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer.
    Yildirim A; Meral M; Kaynar H; Polat H; Ucar EY
    Med Sci Monit; 2007 Apr; 13(4):CR195-200. PubMed ID: 17392651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.